How to Take Wegovy for Weight Loss: What the Instructions Don't Make Clear

The myth: the starter dose is too weak, so faster is better

A lot of people start Wegovy at 0.25 mg and feel nothing (no reduced appetite, no change in energy) and wonder whether the dose is faulty or the medicine is not working for them. It isn't faulty. The 0.25 mg starting dose exists entirely to settle your gut before the therapeutic doses begin. Jumping the schedule, skipping ahead, or sourcing a higher-strength pen to start faster is one of the most common errors our prescribers hear about from people transferring to us from other providers.

The licensed titration pathway for Wegovy injection is 0.25 mg, then 0.5 mg, 1.0 mg, 1.7 mg and finally 2.4 mg, with roughly four weeks at each level. As of January 2026, a 7.2 mg maintenance dose has also received MHRA approval, but that too is reached gradually, via the same foundational steps. Rushing that ladder almost always means worse nausea, vomiting, or fatigue, and no better weight-loss outcome. Slow is not a design flaw; it is the mechanism.

The NHS medicines page for semaglutide sets this out plainly. Your prescriber, not an article or a forum, decides the pace of your titration based on how you are tolerating each dose.

Injection technique: the practical steps that make a real difference

Wegovy is injected into subcutaneous fat (the layer just beneath the skin) not into muscle. The three licensed sites are the abdomen (at least 5 cm from the navel), the front of the thigh, and the outer upper arm. Rotate within and between those sites. Injecting into the same small patch repeatedly creates scar tissue over time, and scar tissue absorbs medicine poorly.

A quick check worth building into your weekly routine: before you pick up the pen, glance at the label to confirm the strength matches what your prescriber has you on at this stage. Takes ten seconds and removes one category of error entirely.

The injection itself: let the pen reach room temperature if it has just come from the fridge (around 30 minutes is typical), clean the site with an alcohol swab, press the pen firmly against the skin, and press the button. The pen clicks and a second click confirms delivery. Hold it in place for a few seconds before removing. Used pens are sharps waste, they should go into a lidded sharps bin, not the household bin. Some local councils collect these; the Wegovy pen recycling page covers the UK options in detail.

The best injection site for Wegovy is the one you can reach comfortably and rotate consistently, the three options are genuinely equivalent in terms of absorption. Choose one that works for your routine.

Storage, timing, and the questions that catch people out

Store unopened Wegovy pens in the fridge at 2–8°C, away from the ice compartment. Once in use, the pen can be kept at room temperature for a limited period, the exact window is stated in the Patient Information Leaflet and on the Wegovy SmPC published on the electronic Medicines Compendium (eMC); never rely on a third-party summary for this detail, because different pen formats carry different instructions.

Pick a fixed day and inject at roughly the same time each week. Tuesday morning before work, Sunday evening, it does not matter which day, only that you are consistent. If life intervenes and you are late by a few hours, that is generally fine. More than five days late: skip and return to your usual schedule. Do not double-dose. For full missed-dose guidance, the Patient Information Leaflet inside your pack is authoritative.

Frequency is probably the most Googled Wegovy question. If you want the detailed answer, the Wegovy injection frequency page walks through it. The short version: once a week, same day each week, always.

Cost is a practical question that comes up once people know the medicine is right for them. The Wegovy price page explains how private treatment is priced in the UK and what an all-in price should include.

Side effects: what is common, what to watch for, and when to seek help

Gastrointestinal side effects (nausea, loose stools, indigestion, constipation, bloating) are common with Wegovy, particularly in the first week or two after starting or stepping up a dose. For most people they are mild, settle as the body adjusts, and are manageable with small meals, staying hydrated, and avoiding very fatty foods. They are not a sign that the medicine is wrong for you; they are a sign it is working on the gut hormones it is designed to affect.

A smaller number of people experience more significant discomfort. The MHRA issued a Drug Safety Update in January 2026 reminding prescribers and patients that acute pancreatitis, though infrequent, is a known risk with GLP-1 medicines: severe, persistent stomach pain that radiates to the back (with or without vomiting) warrants urgent medical attention. Gallbladder symptoms (pain in the upper right abdomen, especially after eating) also warrant prompt review. If you experience a serious allergic reaction, severe dehydration from persistent vomiting, or low mood or thoughts of self-harm, contact a healthcare professional or emergency services without delay. Report any suspected side effects via the MHRA Yellow Card scheme.

Injection-site reactions (redness, mild swelling, itching) are common and usually brief. Rotating sites as described above is the main preventive measure.

For a fuller picture of how Wegovy works and who it is licensed for in the UK, the Wegovy weight-loss injections overview covers the clinical background in one place, and if you would like to understand how the Wegovy weight loss pen is designed and what to expect from it before you begin, that page is a useful starting point. And if you are weighing up whether Wegovy or tirzepatide is a better fit for your situation, that is exactly the conversation a prescriber at our pharmacy is well-placed to have with you, at no cost, on the same day you submit your consultation.

When you are ready, start your free consultation and a GPhC-registered prescriber will review your answers the same day.